文献速递主动脉疾病

移动式与固定式C臂荧光透视下行血管腔内主动脉修复的辐射剂量及手术各阶段辐射分布

Radiation doses for endovascular aortic repairs performed on mobile and fixed C-arm fluoroscopes and procedure phase-specific radiation distribution.
PubMed 文献 · J Vasc Surg · 2018-06-28

该研究纳入2009年11月至2016年6月期间使用单一支架系统行血管腔内动脉瘤修复(EVAR)的160例患者,按所用C臂类型分为移动式C臂(MA)组107例和固定式C臂(FA)组53例。结果显示FA组造影剂用量显著低于MA组,但剂量面积乘积显著高于MA组,透视时间无显著差异;分阶段分析显示近端锚定区识别和主体释放阶段辐射最高,占总量24%,数字减影血管造影占47.6%。

要点

  • FA组造影剂用量85.37±38.79 mL vs MA组108.55±42.28 mL(P=0.0014)。
  • FA组剂量面积乘积168.34±146.92 Gy·cm2 vs MA组49.93±38.06 Gy·cm2(P<0.0001)。
  • 近端锚定区识别和主体释放阶段辐射最高,占总剂量24%。

核心结论

  • 使用固定式C臂系统可显著减少EVAR所需造影剂用量,但可能导致更高的辐射剂量。
  • 剂量监测对患者和操作者的安全仍然至关重要。
  • 现代系统可进行详细的剂量分布分析,未来可能改善监测质量。

研究设计与样本

  • 研究纳入2009年11月至2016年6月期间使用单一支架系统行EVAR的患者,按所用C臂类型分为移动式C臂(MA)组和固定式C臂(FA)组。
  • 共纳入160例患者,平均年龄73.30±8.97岁,其中男性146例;MA组107例,FA组53例。
  • 前瞻性记录患者人口学数据、造影剂总量、剂量面积乘积和透视时间。
  • 基于FA系统的剂量报告,识别出五个标准阶段和两个可选阶段以确定剂量分布。

主要发现

  • MA组平均造影剂用量为108.55±42.28 mL,FA组为85.37±38.79 mL(P=0.0014)。
  • MA组平均总剂量面积乘积为49.93±38.06 Gy·cm2,FA组为168.34±146.92 Gy·cm2(P<0.0001)。
  • 两组间透视时间无显著差异。
  • 分阶段分析显示,近端锚定区识别和主体释放所需辐射最多,占总辐射剂量的24%。
  • 总体而言,47.6%的曝光来自数字减影血管造影。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to analyze radiation risk to patients during endovascular aneurysm repair (EVAR) using mobile C-arm (MA) or fixed C-arm (FA) fluoroscopes and to describe the dose distribution during the different phases of the procedure. METHODS: Patients treated with EVAR using a single stent graft system between November 2009 and June 2016 were included in this study. The patients were divided into one of two groups (MA or FA) according to the type of C-arm used in the procedure. Data regarding patients' demographics and the total amount of contrast agent (CA) used, dose-area product, and fluoroscopy time for the procedures were prospectively recorded. Based on the dose report from the FA system, five standard and two optional phases of the procedure were identified to determine the dose distribution. RESULTS: Overall, 160 patients were included (mean age, 73.30 ± 8.97 years; 146 men); of these, 107 were treated with an MA system and 53 were treated with an FA system. The mean amounts of CA used were 108.55 ± 42.28 mL in the MA group and 85.37 ± 38.79 mL in the FA group (P = .0014). The mean total dose-area product values were 49.93 ± 38.06 Gy·cm2 in the MA group and 168.34 ± 146.92 Gy·cm2 in the FA group (P < .0001). There was no significant difference in fluoroscopy time between the groups. Per-phase analysis demonstrated that identification of the proximal landing zone and main body deployment required the most radiation, accounting for 24% of the total radiation dose. Overall, 47.6% of the exposure was due to digital subtraction angiography. CONCLUSIONS: Use of an FA system can significantly reduce the amount of CA needed but may also lead to higher radiation doses in EVAR procedures. Dose monitoring remains crucial for the safety of both patients and operators. A detailed analysis of dose distribution is possible with modern systems, which may improve the quality of monitoring in the future.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Schaefers JF, Wunderle K, Usai MV, et al. Radiation doses for endovascular aortic repairs performed on mobile and fixed C-arm fluoroscopes and procedure phase-specific radiation distribution. J Vasc Surg. 2018. PMID: 30473030. doi:10.1016/j.jvs.2018.05.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。